Revvity Signals Software

What Revvity Signals Software does

Revvity Signals Software, formerly PerkinElmer Informatics, is a Waltham, Massachusetts-based enterprise scientific software provider serving pharmaceutical, biotechnology, chemical, agrichemical, and electronics research organizations. The company offers a portfolio of platforms centered on AI-enhanced R&D data management, electronic laboratory notebooks (ELNs), and cheminformatics — including Signals One (a unified AI-enhanced data management platform for drug discovery and formulation workflows), Signals Notebook (core ELN), Signals Lead Discovery (molecule filtering and process optimization), Signals Xynthetica (Models-as-a-Service for molecular modeling and simulation), and the long-standing ChemDraw chemical drawing software, which celebrated its 40th anniversary in 2025. The platform integrates with enterprise systems (SAP), laboratory instruments (via Scitara), and chemical intelligence tools (ACD/Labs), enabling unified data environments across globally distributed R&D operations.

The company's go-to-market is an enterprise field sales motion targeting large organizations requiring standardized R&D platforms, as evidenced by direct implementations at dsm-firmenich, PI Industries, and EMD Electronics. It supplements direct sales with industry conference participation (Bio-IT World), the NEXUS India customer forum for community engagement, and sponsored content in trade publications. Revvity Signals generates revenue primarily through subscription-based enterprise software licenses for ELN and informatics platforms, supplemented by ChemDraw licensing. Implementation costs for ELN deployments typically range from $60K to $250K, consistent with enterprise software benchmarks. The company operates as a subsidiary or business unit within the broader Revvity organization, with no disclosed standalone funding or public listing.

Name

Revvity Signals Software

Website

https://perkinelmerinformatics.com

Company type

Private

Operating status

Operating

Headcount range

251–500 employees

Short description

Revvity Signals Software (formerly PerkinElmer Informatics) provides AI-enhanced R&D data management, electronic laboratory notebooks, and cheminformatics platforms — including Signals One, Signals Notebook, Signals Xynthetica, and ChemDraw — to pharmaceutical, biotechnology, chemical, agrichemical, and electronics research enterprises globally.

Ownership category

akta.pro rank

Product category

Scientific R&D Software / Laboratory Informatics

NAICS

Computer Systems Design and Related Services (54151)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

Quality, Compliance & Validation Software for Labs (GxP/CSV, eQMS for QC Labs) (HLAGAJAI)

Keywords

• Scientific R&D software
• Electronic laboratory notebook
• Drug discovery informatics
• Cheminformatics software
• Formulation data management

Headquarters

HQ city

Waltham

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations

Revenue model

1. Enterprise Software Licenses and Subscriptions: Revvity Signals operates as an enterprise software provider offering platforms such as Signals One, Signals Notebook, and Signals Lead Discovery to organizations in the pharmaceutical, biotechnology, chemical, and materials research sectors. Revenue is generated through software licensing and subscription models targeting enterprise customers requiring standardized R&D data management solutions.
2. ELN and Informatics Platform Licensing: The company's offerings compete in the global Electronic Laboratory Notebook (ELN) market valued at approximately USD 700 million, with Revvity Signals positioned as a key player alongside Benchling, LabArchives, Thermo Fisher Scientific, and PerkinElmer.
3. ChemDraw™ Licensing: Revvity Signals is the company behind ChemDraw™, a widely used chemical drawing and informatics tool celebrating its 40th anniversary, representing a long-standing product line generating licensing revenue.

Pricing tiers

Go-to-market motion3 records

Distribution channels1 record

Marketing channels5 records

Core offering

Revvity Signals Software develops and sells enterprise scientific R&D software platforms, including AI-enhanced R&D data management (Signals One™), electronic laboratory notebooks (Signals Notebook), lead discovery tools, Models-as-a-Service AI capabilities (Signals Xynthetica™), and the long-standing ChemDraw™ chemical drawing software. The offerings target pharmaceutical, biotechnology, specialty chemicals, agrichemical, and electronics/semiconductor materials research organizations worldwide.

Product overview

Revvity Signals Software offers an integrated platform of scientific software solutions for R&D workflows, combining electronic laboratory notebooks, data management, and AI-enhanced analytics. The portfolio centers on Signals One™ as the unified AI-enhanced platform, complemented by Signals Notebook (core ELN product), Lead Discovery platform, and Signals Xynthetica™ (Models-as-a-Service). The company also maintains the ChemDraw™ brand (celebrating its 40th anniversary) as a key chemical drawing tool within its portfolio. The platform architecture supports formulation R&D, drug discovery, and specialty chemicals development through integrated data management, AI-powered predictive modeling, and collaborative workflows.

Differentiator

Problem solved

Functional benefit

Brands

• Signals One™: AI-enhanced R&D data management platform designed for formulation and specialty chemicals teams, described as a unified solution for managing formulation data, workflows, analytics, and scientific knowledge.
• Signals Xynthetica™
• Signals Notebook
• Lead Discovery
• ChemDraw™

Products and services

• Signals One™ AI-enhanced R&D data management platform designed for formulation and specialty chemicals teams, providing a unified solution for managing formulation data, workflows, analytics, and scientific knowledge across the R&D lifecycle. Includes AI-powered predictive modeling, cross-team collaboration tools, and embedded sustainability metrics.
• Signals Notebook Standardized electronic laboratory notebook (ELN) platform for capturing, organizing, and sharing scientific data across organizations. Enables global collaboration and knowledge management in R&D environments with agile framework support and continuous platform enhancement.
• Lead Discovery Platform designed for lead discovery workflows in agrichemicals and pharmaceutical research. Enables filtering of investigational molecules, optimization of chemical processes, and collaboration across globally distributed R&D, manufacturing, and distribution operations.
• Signals Xynthetica™ (Models-as-a-Service) Models-as-a-Service platform providing AI-driven molecular modeling and simulation capabilities for chemical and formulation applications as part of the AI integration strategy.
• ChemDraw™ Industry-standard chemical drawing software used for creating and editing chemical structures, reactions, and biological sequences. Long-standing product line with 40+ year heritage generating licensing revenue.

Quantifiable outcome

• 50% faster time-to-market for formulation and specialty chemicals teams using Signals One™
• +3 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability6 records

Feature9 records

Partnerships

Two partnerships are on record, tiered core and strategic.

• ScitaracoreTechnology or Integration · 28 July 2026EMD Electronics partnered with Revvity Signals and Scitara to implement a cloud-native data integration system that unifies research data from multiple instruments, enhancing advanced analytics and AI capabilities. The solution automates data collection, structuring, and visualization, improving research efficiency and collaboration. This partnership enables Revvity Signals to offer end-to-end laboratory data connectivity alongside its ELN and informatics platforms.
• ACD/LabsstrategicTechnology or Integration · 1 January 2025Revvity Signals announced plans to integrate ACD/Labs technologies into its platform as part of its 2025 product roadmap. This integration will add chemical intelligence capabilities to the Revvity Signals platform, strengthening its offering for chemoinformatics and molecular analysis applications.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Benchling: Benchling is a cloud-native life sciences R&D platform offering ELN, inventory, and workflow management for biotech and pharma organizations. Directly competes with Revvity Signals' Signals Notebook and Signals One in core ELN and R&D data management with a modern SaaS architecture.
• Dotmatics: Dotmatics provides scientific informatics software including ELN, data management, and analysis for drug discovery and chemistry research. Directly competes across Revvity Signals' core informatics and chemoinformatics portfolio, serving similar pharma and biotech customers.
• Schrödinger: Schrödinger offers computational chemistry and drug discovery informatics platforms including predictive modeling and molecular simulation. Directly comparable to Revvity Signals' chemoinformatics and Signals Xynthetica Models-as-a-Service offerings, serving the same pharmaceutical R&D customers.
• LabArchives: LabArchives is an electronic lab notebook (ELN) provider widely used in academic and research institutions. Directly competes with Revvity Signals Notebook in the ELN category, though with stronger academic rather than enterprise positioning.
• Chemaxon: Chemaxon provides chemoinformatics software platforms for chemical structure drawing, search, and analysis. Directly overlaps with Revvity Signals' ChemDraw and chemoinformatics capabilities, serving similar chemistry research customers.
• IDBS: IDBS provides scientific data management and ELN solutions for life sciences R&D, including the E-WorkBook platform. Directly comparable to Revvity Signals Notebook and Lead Discovery offerings, particularly in pharma and biotech R&D informatics.
• OpenEye Scientific (Cadence Molecular Sciences): OpenEye Scientific (now part of Cadence Molecular Sciences) provides molecular modeling and chemoinformatics software for pharmaceutical research. Directly comparable to Revvity Signals' chemoinformatics and Signals Xynthetica offerings in drug discovery informatics.

Broad incumbents

• Dassault Systèmes (BIOVIA): Dassault Systèmes' BIOVIA division provides a broad portfolio of scientific informatics including ELN, molecular modeling, and laboratory management. Operates as a larger incumbent with overlapping capabilities across Revvity Signals' portfolio but as part of a much wider PLM and design software portfolio.
• Thermo Fisher Scientific (Informatics): Thermo Fisher Scientific offers informatics and laboratory software solutions as part of its broader scientific instruments and life sciences portfolio. Competes with Revvity Signals in ELN and sample management but as part of a much larger instrumentation and consumables business.

Emerging players

• Sapio Sciences: Sapio Sciences offers an integrated ELN, LIMS, and scientific data management platform with a no-code configuration approach. Emerging player with partial overlap in life sciences R&D informatics, increasingly competing for enterprise pharma and biotech ELN deals.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Revvity Signals Software